Ignite Creation Date:
2025-12-24 @ 7:09 PM
Ignite Modification Date:
2025-12-27 @ 12:39 AM
Study NCT ID:
NCT03181503
Status:
COMPLETED
Last Update Posted:
2020-02-19
First Post:
2017-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Nemolizumab in PN
Sponsor:
Galderma R&D
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-02
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2017-06-07
First Submit QC Date:
None
Study First Post Date:
2017-06-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2019-10-07
Results First Submit QC Date:
None
Results First Post Date:
2020-02-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-07
Last Update Post Date:
2020-02-19
Last Update Post Date Type:
ACTUAL